Nomura Holdings’s Sage Therapeutics SAGE Stock Holding History

Nomura Holdings’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-80,000	Closed	-$730K	–	2055
2025 Q2	$730K	Buy	80,000 +49,696	+164%	+$366K	﹤0.01%	1066
2025 Q1	$241K	Sell	30,304 -8	-0%	-$59	﹤0.01%	1644
2024 Q4	$165K	Buy	+30,312	New	+$185K	﹤0.01%	2078

Other funds holding SAGE

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nomura Holdings's SAGE Position: Q3 2025 in Review

Nomura Holdings sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 80,000 shares — an estimated $730K sold.

Nomura Holdings first reported a position in SAGE in Q4 2024 and held it in 3 quarters. The position peaked at $730K in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

Nomura Holdings reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
Nomura Holdings sold 80,000 Sage Therapeutics shares in Q3 2025, an estimated $730K.
Nomura Holdings first reported a position in Sage Therapeutics in Q4 2024 and held it in 3 quarters.
Nomura Holdings's Sage Therapeutics position peaked at $730K in Q2 2025.
5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Nomura Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.